CUMBERLAND PHARMACEUTICALS INC business relationships

Companies named in CUMBERLAND PHARMACEUTICALS INC’s 10-K filed 2026-03-09, and public companies whose annual reports name CUMBERLAND PHARMACEUTICALS INC. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 5.4 / 10
AI naming: 70 / 100
Agent readiness: 5 / 100
AI adoption: 0 / 100

Named in CUMBERLAND PHARMACEUTICALS INC’s annual report 11

NOVARTIS AG (NVS)Partner7.7
“WinHealth has established partnerships with international companies that include Boehringer-Ingelheim, Janssen, Novartis, Pfizer and Roche, generating several hundred million dollars in sales annually.” SEC filing
PFIZER INC (PFE)Partner7.7
“WinHealth has established partnerships with international companies that include Boehringer-Ingelheim, Janssen, Novartis, Pfizer and Roche, generating several hundred million dollars in sales annually.” SEC filing
Roche GroupPartner7.7
“WinHealth has established partnerships with international companies that include Boehringer-Ingelheim, Janssen, Novartis, Pfizer and Roche, generating several hundred million dollars in sales annually.” SEC filing
Hikma Pharmaceuticals PLCSales channel5.5
“• Acetaminophen and ibuprofen combination injection (brand name Combogesic ® ), is a combination of acetaminophen and ibuprofen approved by the U.S. FDA in October 2023, and is sold by Hikma Pharmaceuticals PLC.” SEC filing
Mallinckrodt plcSales channel5.4
“• IV acetaminophen (brand name Ofirmev ® ), an injectable analgesic product is sold by Mallinckrodt plc, and there are also generic versions from different manufacturers available;” SEC filing
PERRIGO Co plc (PRGO)Supplier5.4
“...Supply Agreement, dated November 9, 2012, by and between Cumberland Pharmaceuticals Inc., Paddock Laboratories, LLC and Perrigo Company incorporated herein by reference to the corresponding exhibit to the Registrant's Annual Report on Form 10-K (File No. 001-33637) as filed with the SEC on March 12,...” SEC filing
CARDINAL HEALTH INC (CAH)Customer5.2
“In 2025, Cardinal Health Specialty Solutions exclusively handled our U.S. product logistics activities, including warehousing, shipping, and various other customer activities.” SEC filing
Phathom Pharmaceuticals, Inc. (PHAT)Sales channel4.7
“Branded, prepackaged combination products includes Voquezna ® Triple Pak ® (vonoprozan/amoxicillin/clarithromycin) and Voquezna Dual Pak ® manufactured and sold by Phathom Pharmaceuticals.” SEC filing
Trevena, Inc.Sales channel4.7
“• Oliceridine injection (brand name Olinvyk ® ), is an opioid agonist, a new chemical entity in the acute surgical postoperative pain market, sold by Trevena, Inc.;” SEC filing
Vizient, Inc.Supplier4.7
“In 2025, we announced the availability of the Vibativ 4-Vial Starter Pak through a new supply arrangement with Vizient Inc., making it accessible to their health care providers nationwide.” SEC filing
Vertex Pharmaceuticals, Inc.Sales channel4.0
“• Suzetrigine oral tablets (brand name Journavx ® ), a product sold by Vertex Pharmaceuticals, Inc., a non-opioid pain signal inhibitor approved by the U.S. FDA in January 2025.” SEC filing

Companies whose annual reports name CUMBERLAND PHARMACEUTICALS INC 1

RedHill Biopharma Ltd. (RDHL)names it as partner3.5
“| | ● | | the ability to successfully commercialize Talicia ® in the U.S as part of our collaboration arrangement with Cumberland Pharmaceuticals Inc. ("Cumberland") and successfully implement joint decision-making and division of responsibilities for such collaboration; |” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.